Article

Repurposing of drugs as novel influenza inhibitors from clinical gene expression infection signatures

2018-08-27

Abstract excerpt

<h4>Background:</h4> Influenza virus infections remain a major and recurrent public health burden. The intrinsic ever-evolving nature of this virus, the suboptimal efficacy of current influenza inactivated vaccines, as well as the emergence of resistance against a limited antiviral arsenal, highlight the critical need for novel therapeutic approaches. In this context, the aim of this study was to develop and vali...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 04dacf8e-abb4-5f6c-8c79-69d478d721cb
DOI: 10.1101/401315

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Repurposing of drugs as novel influenza inhibitors from clinical gene expression infection signaturesDOI 10.1101/401315Read

A genetically based computational drug repurposing framework for rapid identification of candidate compounds: application to COVID-19Semantic proximity Read

Systematic Cell Line-Based Identification of Drugs Modifying <i>ACE2</i> ExpressionSemantic proximity Read

Computational drug repurposing against SARS-CoV-2 reveals plasma membrane cholesterol depletion as key factor of antiviral drug activitySemantic proximity Read

An Integrative in Silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main ProteaseSemantic proximity Read

Rapid Therapeutic Recommendations in the Context of a Global Public Health Crisis using Translational Bioinformatics Approaches: A proof-of-concept study using Nipah Virus InfectionSemantic proximity Read

Genetic screens for the control of influenza virus replication: from meta-analysis to drug discoverySemantic proximity Read

Systematic transcriptomic analysis enables targeted drug repurposing for neurotropic flavivirus infectionsSemantic proximity Read

Host gene targets for novel influenza therapies elucidated by high‐throughput RNA interference screensSemantic proximity Read

A Comprehensive SARS-CoV-2 Genomic Analysis Identifies Potential Targets for Drug RepurposingSemantic proximity Read

Drug Repurposing of potential drug targets for treatment of COVID-19Semantic proximity Read

Analysis of Infected Host Gene Expression Reveals Repurposed Drug Candidates and Time-Dependent Host Response Dynamics for COVID-19Semantic proximity Read

In silico Drug Repurposing to combat COVID-19 based on Pharmacogenomics of Patient Transcriptomic DataSemantic proximity Read